Second-quarter sales of AstraZeneca’s (AZN.L) COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker …
Big jumps in sales of prescription drugs & medical devices helped Johnson & Johnson boost its first-quarter profit by nearly 7%.
The United States has pledged $4 billion to the global COVAX vaccine program that aims to deliver coronavirus vaccines to poor countries.
U.S. retail sales are expected to continue to grow this year, according to a new estimate from the National Retail Federation.
US pharma major Pfizer Inc expects to earn $15 billion, or about a quarter of its total revenue this year, from the sales of its COVID-19 vaccine.
The country is scheduled to start vaccinations in March 2021 and expects to inoculate its whole population by the end of the year.
U.K. health authorities have rolled out the first doses of a widely tested and independently reviewed COVID-19 vaccine, starting a global immunization program that is expected to gain momentum as more serums win approval.